Three types of parameters summarized from the procedures of parameter sensitivity analysis by 11 state-of-the-art computational models
Type of parameters analyzed . | Models performing the analysis . |
---|---|
Matrix decomposition/completion-related parameters | |
The regularization coefficients in the objective function | MLPMDA [21] |
M2LFL [10] | |
NIMCGCN [28] | |
TDRC [30] | |
The dimensionality parameter for latent feature representation matrices of miRNAs and diseases | M2LFL [10] |
GRNMF [20] | |
TDRC [30] | |
The number of computation layers for matrix decomposition/completion | MLPMDA [21] |
The maximum number of iterations for optimizing the objective function | GRNMF [20] |
Deep learning-related parameters | |
The regularization coefficients in the loss function | M2LFL [10] |
GRNMF [20] | |
The size of miRNA and disease embeddings | AEMDA [17] |
MMGCN [9] | |
GAEMDA [37] | |
The learning rate | MMGCN [9] |
The number of filters in convolutional neural network | MMGCN [9] |
The number of neural network layers | MVMTMDA [15] |
MMGCN [9] | |
NMCMDA [36] | |
GAEMDA [37] | |
NIMCGCN [28] | |
The negative sampling ratio | MVMTMDA [15] |
miRNA- and disease-related parameters | |
MiRNAs and diseases’ k nearest neighbours, whose similarity features were used to update the MDA adjacency matrix | MLPMDA [21] |
GRNMF [20] | |
Weights for constructing integrated similarity matrices of miRNAs and diseases | MLPMDA [21] |
AEMDA [17] | |
Parameter k of the KNN classifier for constructing the edges between the MDP nodes in the homogeneous graph | MDA–GCNFTG [32] |
Type of parameters analyzed . | Models performing the analysis . |
---|---|
Matrix decomposition/completion-related parameters | |
The regularization coefficients in the objective function | MLPMDA [21] |
M2LFL [10] | |
NIMCGCN [28] | |
TDRC [30] | |
The dimensionality parameter for latent feature representation matrices of miRNAs and diseases | M2LFL [10] |
GRNMF [20] | |
TDRC [30] | |
The number of computation layers for matrix decomposition/completion | MLPMDA [21] |
The maximum number of iterations for optimizing the objective function | GRNMF [20] |
Deep learning-related parameters | |
The regularization coefficients in the loss function | M2LFL [10] |
GRNMF [20] | |
The size of miRNA and disease embeddings | AEMDA [17] |
MMGCN [9] | |
GAEMDA [37] | |
The learning rate | MMGCN [9] |
The number of filters in convolutional neural network | MMGCN [9] |
The number of neural network layers | MVMTMDA [15] |
MMGCN [9] | |
NMCMDA [36] | |
GAEMDA [37] | |
NIMCGCN [28] | |
The negative sampling ratio | MVMTMDA [15] |
miRNA- and disease-related parameters | |
MiRNAs and diseases’ k nearest neighbours, whose similarity features were used to update the MDA adjacency matrix | MLPMDA [21] |
GRNMF [20] | |
Weights for constructing integrated similarity matrices of miRNAs and diseases | MLPMDA [21] |
AEMDA [17] | |
Parameter k of the KNN classifier for constructing the edges between the MDP nodes in the homogeneous graph | MDA–GCNFTG [32] |
Three types of parameters summarized from the procedures of parameter sensitivity analysis by 11 state-of-the-art computational models
Type of parameters analyzed . | Models performing the analysis . |
---|---|
Matrix decomposition/completion-related parameters | |
The regularization coefficients in the objective function | MLPMDA [21] |
M2LFL [10] | |
NIMCGCN [28] | |
TDRC [30] | |
The dimensionality parameter for latent feature representation matrices of miRNAs and diseases | M2LFL [10] |
GRNMF [20] | |
TDRC [30] | |
The number of computation layers for matrix decomposition/completion | MLPMDA [21] |
The maximum number of iterations for optimizing the objective function | GRNMF [20] |
Deep learning-related parameters | |
The regularization coefficients in the loss function | M2LFL [10] |
GRNMF [20] | |
The size of miRNA and disease embeddings | AEMDA [17] |
MMGCN [9] | |
GAEMDA [37] | |
The learning rate | MMGCN [9] |
The number of filters in convolutional neural network | MMGCN [9] |
The number of neural network layers | MVMTMDA [15] |
MMGCN [9] | |
NMCMDA [36] | |
GAEMDA [37] | |
NIMCGCN [28] | |
The negative sampling ratio | MVMTMDA [15] |
miRNA- and disease-related parameters | |
MiRNAs and diseases’ k nearest neighbours, whose similarity features were used to update the MDA adjacency matrix | MLPMDA [21] |
GRNMF [20] | |
Weights for constructing integrated similarity matrices of miRNAs and diseases | MLPMDA [21] |
AEMDA [17] | |
Parameter k of the KNN classifier for constructing the edges between the MDP nodes in the homogeneous graph | MDA–GCNFTG [32] |
Type of parameters analyzed . | Models performing the analysis . |
---|---|
Matrix decomposition/completion-related parameters | |
The regularization coefficients in the objective function | MLPMDA [21] |
M2LFL [10] | |
NIMCGCN [28] | |
TDRC [30] | |
The dimensionality parameter for latent feature representation matrices of miRNAs and diseases | M2LFL [10] |
GRNMF [20] | |
TDRC [30] | |
The number of computation layers for matrix decomposition/completion | MLPMDA [21] |
The maximum number of iterations for optimizing the objective function | GRNMF [20] |
Deep learning-related parameters | |
The regularization coefficients in the loss function | M2LFL [10] |
GRNMF [20] | |
The size of miRNA and disease embeddings | AEMDA [17] |
MMGCN [9] | |
GAEMDA [37] | |
The learning rate | MMGCN [9] |
The number of filters in convolutional neural network | MMGCN [9] |
The number of neural network layers | MVMTMDA [15] |
MMGCN [9] | |
NMCMDA [36] | |
GAEMDA [37] | |
NIMCGCN [28] | |
The negative sampling ratio | MVMTMDA [15] |
miRNA- and disease-related parameters | |
MiRNAs and diseases’ k nearest neighbours, whose similarity features were used to update the MDA adjacency matrix | MLPMDA [21] |
GRNMF [20] | |
Weights for constructing integrated similarity matrices of miRNAs and diseases | MLPMDA [21] |
AEMDA [17] | |
Parameter k of the KNN classifier for constructing the edges between the MDP nodes in the homogeneous graph | MDA–GCNFTG [32] |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.